LISATA THERAPEUTICS, INC. Common Stock, Value, Issued
LISATA THERAPEUTICS, INC. (LSTA) had Common Stock, Value, Issued of $9.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-06
- 2026-06-30: Common Stock, Value, Issued $9.00K.
- 2026-03-31: Common Stock, Value, Issued $9.00K.
- 2025-12-31: Common Stock, Value, Issued $9.00K.
- 2025-09-30: Common Stock, Value, Issued $9.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $9.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $9.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $9.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $9.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $9.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $8.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $8.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $8.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $8.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $8.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $8.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $8.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $8.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $8.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $8.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $61.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $61.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $4.00K 10-K · filed 2023-03-30 | $60.00K 10-K · filed 2022-03-22 |
| 2021-09-30 | $60.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $60.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $60.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $19.00K 10-K · filed 2022-03-22 | |
| 2020-09-30 | $19.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $16.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $11.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $11.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $10.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $10.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $10.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $10.00K 10-K · filed 2020-03-05 | |
| 2018-09-30 | $9.85K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $9.73K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $9.57K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $9.00K 10-K · filed 2019-03-14 | $9.48K 10-K · filed 2018-03-22 |
| 2017-09-30 | $9.43K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $8.91K 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $8.95K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $8.21K 10-K · filed 2018-03-22 | |
| 2016-09-30 | $8.18K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $5.93K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $59.12K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $5.67K 10-K · filed 2017-03-17 | $56.73K 10-K · filed 2016-03-15 |
| 2015-09-30 | $55.50K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $55.45K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $39.42K 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $36.78K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $35.49K 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $34.94K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $28.59K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $27.20K 10-K · filed 2015-03-02 | |
| 2013-09-30 | $21.19K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $19.58K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $170.28K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $16.38K 10-K · filed 2014-03-13 | $163.75K 10-K · filed 2013-03-11 |
| 2012-09-30 | $155.14K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $137.62K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $129.89K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $109.33K 10-K · filed 2013-03-11 | |
| 2011-09-30 | $100.36K 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $82.25K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $63.81K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |